Innovative Healthcare R&D Platforms : medical technology industry

Veranex recently introduced the medical technology industry’s first Innovation CRO (iCRO). This innovation represents a transformative approach to medical device and diagnostic development as it addresses critical challenges in today’s constrained funding environment.

Veranex’s integrated service model combines traditional contract research organization capabilities with comprehensive product development expertise across the entire lifecycle — from initial concept through regulatory approval and market access. The iCRO framework operates through four foundational elements, including accelerated development timelines promising three to six month reductions per phase, evidence generation strategies coordinated from project inception, specialized therapeutic area knowledge across 1,000+ completed programs, and proven regulatory pathways boasting a 96% approval rate.

Veranex’s solution for the medical technology industry embeds reimbursement strategists and human factors engineers alongside designers and clinical researchers from the outset.

Image Credit: Veranex